We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Targeting the Tumor Microenvironment

Article   Mar 17, 2020 | By Joanna Owens, PhD

 
Targeting the Tumor Microenvironment
 
 
Advertisement
 

RELATED ARTICLES

The Coronavirus Outbreak

Article

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to the outbreak.

READ MORE

What Led to Reagent Shortages for Coronavirus Testing in the US?

Article

Testing the right person is a crucial aspect in any pandemic. Apart from saving lives, widespread testing can provide important data required to model the course of the outbreak. Reagents are a critical component of testing. Unfortunately, many US labs have struggled to procure the reagents needed to perform large batches of coronavirus diagnostic testing.

READ MORE

A Point-of-Care CRISPR-based COVID-19 Diagnostic Could Be on the Horizon

Article

The lab of Dr Changchun Liu at the University of Connecticut Health Center is developing a simple, low-cost, CRISPR-based method which can detect infectious diseases such as COVID-19. Technology Networks spoke to Dr Liu to learn more about the method and the next steps to be taken before a point-of-care diagnostic test using it could become widely available.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE